A Review of Consent Practices and Perspectives for Pharmacogenetic testing

References

• Haga SB , MoaddebJ . Comparison of delivery strategies for pharmacogenetic testing services . Pharmacogenet. Genomics24 ( 3 ), 139 – 145 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Dunnenberger HM , CrewsKR , HoffmanJMet al. Preemptive clinical pharmacogenetics implementation: current programs in five US medical centers . Annu. Rev. Pharmacol. Toxicol.55 , 89 – 106 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Institute of Medicine . Crossing the Quality Chasm: a New Health System for the 21st Century . National Academy Press , Washington, DC, USA ( 2001 ).
   Google Scholar
• American Medical Association . Opinion 8.08 - Informed Consent . www.ama-assn.org/ama/pub/physician-resources/medical-ethics/code-medical-ethics/opinion808.page .
   Google Scholar
• Coleman CH , SelgelidMJ , ReisA , ReichmanLB , JaramilloE . The role of informed consent in tuberculosis testing and screening . Eur. Respir. J.39 ( 5 ), 1057 – 1059 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention . State HIV testing laws: consent and counseling requirements . www.cdc.gov/hiv/policies/law/states/testing.html .
   Google Scholar
• Beckwith J , GellerL , HallMA , SharpeNF , CarterRF . Informed consent . In : Genetic Testing: Care Consent, and Liability . SharpeNF , CarterRF ( Eds ). John Wiley & Sons, Inc. , NJ, USA , 128 – 162 ( 2006 ).
   Google Scholar
• Rieger PT , PentzRD . Genetic testing and informed consent . Semin. Oncol. Nurs.15 ( 2 ), 104 – 115 ( 1999 ).
   PubMedGoogle Scholar
• Joint Committee on Medical Genetics . Consent and confidentiality in clinical genetic practice: guidance on genetic testing and sharing genetic information. 2nd Edition ( 2011 ). www.bsgm.org.uk/media/678746/consent_and_confidentiality_2011.pdf .
   Google Scholar
• Ayuso C , MillanJM , ManchenoM , Dal-ReR . Informed consent for whole-genome sequencing studies in the clinical setting. Proposed recommendations on essential content and process . Eur. J. Hum. Genet.21 ( 10 ), 1054 – 1059 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• American College of Medical Genetics and Genomics . Policy statement: points to consider in the application of genomic sequencing . www.acmg.net/StaticContent/PPG/Clinical_Application_of_Genomic_Sequencing.pdf .
   Google Scholar
• American College of Medical Genetics Board of Directors . Points to consider for informed consent for genome/exome sequencing . Genet. Med.15 ( 9 ), 748 – 749 ( 2013 ).
   PubMedGoogle Scholar
• Goldman JS , HahnSE , CataniaJWet al. Genetic counseling and testing for Alzheimer disease: joint practice guidelines of the American College of Medical Genetics and the National Society of Genetic Counselors . Genet. Med.13 ( 6 ), 597 – 605 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Berliner JL , FayAM , CummingsSA , BurnettB , TillmannsT . NSGC practice guideline: risk assessment and genetic counseling for hereditary breast and ovarian cancer . J. Genet. Couns.22 ( 2 ), 155 – 163 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• American Society of Clinical Oncology . American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility . J. Clin. Oncol.21 ( 12 ), 2397 – 2406 ( 2003 ).
   PubMed Web of Science ®Google Scholar
• Payne K , FargherEA , RobertsSAet al. Valuing pharmacogenetic testing services: a comparison of patients’ and health care professionals’ preferences . Value Health14 ( 1 ), 121 – 134 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Zhang SC , BruceC , HaydenM , RiederMJ . Public perceptions of pharmacogenetics . Pediatrics133 ( 5 ), e1258 – e1267 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Fargher EA , EddyC , NewmanWet al. Patients’ and healthcare professionals’ views on pharmacogenetic testing and its future delivery in the NHS . Pharmacogenomics8 ( 11 ), 1511 – 1519 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Hoop JG , LapidMI , PaulsonRM , RobertsLW . Clinical and ethical considerations in pharmacogenetic testing: views of physicians in 3 “early adopting” departments of psychiatry . J. Clin. Psychiatry71 ( 6 ), 745 – 753 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Drozda K , MullerDJ , BishopJR . Pharmacogenomic testing for neuropsychiatric drugs: current status of drug labeling, guidelines for using genetic information, and test options . Pharmacotherapy34 ( 2 ), 166 – 184 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• National Center for Biotechnology Information . Genetic Testing Registry . www.ncbi.nlm.nih.gov/gtr/ .
   Google Scholar
• Centers for Disease Control and Prevention . Examples of state-required components of informed consent for genetic testing . MMWR58 ( RR06 ), 33 – 34 ( 2009 ).
   Google Scholar
• New York Civil Rights Law § 79-L . Confidentiality of records of genetic tests . www.wadsworth.org/labcert/regaffairs/clinical/79_L_1_2002.pdf .
   Google Scholar
• Del Carmen MG , JoffeS . Informed consent for medical treatment and research: a review . Oncologist10 ( 8 ), 636 – 641 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Beauchamp TL , ChildressJF . Principles of Biomedical Ethics (Third Edition) . Oxford University Press , NY, USA , 1 – 470 ( 1989 ).
   Google Scholar
• Woelderink A , IbarretaD , HopkinsMM , Rodriguez-CerezoE . The current clinical practice of pharmacogenetic testing in Europe: TPMT and HER2 as case studies . Pharmacogenomics J.6 ( 1 ), 3 – 7 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Hedgecoe A . ‘At the point at which you can do something about it, then it becomes more relevant’: informed consent in the pharmacogenetic clinic . Soc. Sci. Med.61 ( 6 ), 1201 – 1210 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Hedgecoe AM . Context, ethics and pharmacogenetics . Stud. Hist. Philos. Biol. Biomed. Sci.37 ( 3 ), 566 – 582 ( 2006 ).
   PubMedGoogle Scholar
• Ruiz-Canela M , Baena-MolinaMJ . Quality of consent forms in pharmacogenetic studies: a survey of research ethics committees in Spain . Per. Med.3 ( 3 ), 231 – 237 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Mcpherson EC , RaySC , RieserPA , ManascoPK . Pharmacogenetic research: perceptions of informed consent . Drug Inf. J.36 ( 1 ), 83 – 93 ( 2002 ).
   Google Scholar
• Hoop JG , RobertsLW , Green HammondKA , CoxNJ . Psychiatrists’ attitudes regarding genetic testing and patient safeguards: a preliminary study . Genet. Test12 ( 2 ), 245 – 252 ( 2008 ).
   PubMedGoogle Scholar
• Rogausch A , PrauseD , SchallenbergA , BrockmollerJ , HimmelW . Patients’ and physicians’ perspectives on pharmacogenetic testing . Pharmacogenomics7 ( 1 ), 49 – 59 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Roses AD . Pharmacogenetics and the practice of medicine . Nature405 ( 6788 ), 857 – 865 ( 2000 ).
   PubMed Web of Science ®Google Scholar
• Nuffield Council on Bioethics . Pharmacogenetics ethical issues ( 2003 ). http://nuffieldbioethics.org/wp-content/uploads/2014/07/Pharmacogenetics-Report.pdf .
   Google Scholar
• Wertz DC . Ethical, social and legal issues in pharmacogenomics . Pharmacogenomics J.3 ( 4 ), 194 – 196 ( 2003 ).
   PubMed Web of Science ®Google Scholar
• Buchanan A , CalifanoA , KahnJ , McphersonE , RobertsonJ , BrodyB . Pharmacogenetics: ethical issues and policy options . Kennedy Inst. Ethics J.12 ( 1 ), 1 – 15 ( 2002 ).
   PubMed Web of Science ®Google Scholar
• Netzer C , Biller-AndornoN . Pharmacogenetic testing, informed consent and the problem of secondary information . Bioethics18 ( 4 ), 344 – 360 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Robertson JA . Consent and privacy in pharmacogenetic testing . Nat. Genet.28 ( 3 ), 207 – 209 ( 2001 ).
   PubMed Web of Science ®Google Scholar
• Robertson JA , BrodyB , BuchananA , KahnJ , McPhersonE . Pharmacogenetic challenges for the health care system . Health Aff.21 ( 4 ), 155 – 167 ( 2002 ).
   Web of Science ®Google Scholar
• Zgheib NK , ArawiT , MahfouzRA , SabraR . Attitudes of health care professionals toward pharmacogenetic testing . Mol Diagn Ther15 ( 2 ), 115 – 122 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Romeo-Malanda S , NicolD . Pharmacogenetic testing: legal considerations for consent, privacy and disclosure . Per. Med.5 ( 2 ), 155 – 161 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Avard D , SilversteinT , SillonG , JolyY . Researchers’ perceptions of the ethical implications of pharmacogenomics research with children . Public Health Genomics12 ( 3 ), 191 – 201 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Horgan D , JansenM , LeyensLet al. An index of barriers for the implementation of personalised medicine and pharmacogenomics in Europe . Public Health Genomics17 ( 5 ), 287 – 298 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Anderson DC , Gomez-MancillaB , SpearBBet al. Elements of informed consent for pharmacogenetic research; perspective of the pharmacogenetics working group . Pharmacogenomics J.2 ( 5 ), 284 – 292 ( 2002 ).
   PubMedGoogle Scholar
• Howard HC , JolyY , AvardD , LaplanteN , PhillipsM , TardifJC . Informed consent in the context of pharmacogenomic research: ethical considerations . Pharmacogenomics J.11 ( 3 ), 155 – 161 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Shaw JL , RobinsonR , StarksH , BurkeW , DillardDA . Risk, reward, and the double-edged sword: perspectives on pharmacogenetic research and clinical testing among Alaska Native people . Am. J. Public Health103 ( 12 ), 2220 – 2225 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Pulley JM , DennyJC , PetersonJFet al. Operational implementation of prospective genotyping for personalized medicine: the design of the Vanderbilt PREDICT project . Clin. Pharmacol. Ther.92 ( 1 ), 87 – 95 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Hoffman JM , HaidarCE , WilkinsonMRet al. PG4KDS: a model for the clinical implementation of pre-emptive pharmacogenetics . Am. J. Med. Genet. C166 ( 1 ), 45 – 55 ( 2014 ).
   Web of Science ®Google Scholar
• Rose D , RussoJ , WykesT . Taking part in a pharmacogenetic clinical trial: assessment of trial participants understanding of information disclosed during the informed consent process . BMC Med. Ethics14 , 34 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Moran C , ThornburgCD , BarfieldRC . Ethical considerations for pharmacogenomic testing in pediatric clinical care and research . Pharmacogenomics12 ( 6 ), 889 – 895 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Warner AW , BhathenaA , GilardiSet al. Challenges in obtaining adequate genetic sample sets in clinical trials: the perspective of the Industry Pharmacogenomics Working Group . Clin. Pharmacol. Ther.89 ( 4 ), 529 – 536 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Mcgovern MM , BenachMO , WallensteinS , DesnickRJ , KeenlysideR . Quality assurance in molecular genetic testing laboratories . JAMA281 ( 9 ), 835 – 840 ( 1999 ).
   PubMed Web of Science ®Google Scholar
• Mcgovern MM , EllesR , BerettaIet al. Report of an international survey of molecular genetic testing laboratories . Community Genet.10 ( 3 ), 123 – 131 ( 2007 ).
   PubMedGoogle Scholar
• Platt J , CoxR , EnnsGM . Points to consider in the clinical use of NGS panels for mitochondrial disease: an analysis of gene inclusion and consent forms . J. Genet. Couns.23 ( 4 ), 594 – 603 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Jamal SM , YuJH , ChongJXet al. Practices and policies of clinical exome sequencing providers: analysis and implications . Am. J. Med. Genet. A161A ( 5 ), 935 – 950 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Green RC , BergJS , GrodyWWet al. ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing . Genet. Med.15 ( 7 ), 565 – 574 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Reiff M , RossK , MulchandaniSet al. Physicians’ perspectives on the uncertainties and implications of chromosomal microarray testing of children and families . Clin. Genet.83 ( 1 ), 23 – 30 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Bradbury AR , Patrick-MillerL , DomchekS . Multiplex genetic testing: reconsidering utility and informed consent in the era of next-generation sequencing . Genet. Med.17 ( 2 ), 97 – 98 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Bradbury AR , Patrick-MillerLJ , EglestonBLet al. Patient feedback and early outcome data with a novel tiered-binned model for multiplex breast cancer susceptibility testing . Genet. Med.18 ( 1 ), 25 – 33 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Bunnik EM , JanssensAC , SchermerMH . A tiered-layered-staged model for informed consent in personal genome testing . Eur. J. Hum. Genet.21 ( 6 ), 596 – 601 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Bernhardt BA , RocheMI , PerryDL , ScollonSR , TomlinsonAN , SkinnerD . Experiences with obtaining informed consent for genomic sequencing . Am. J. Med. Genet. A167 ( 11 ), 2635 – 2646 ( 2015 ).
   Web of Science ®Google Scholar
• Zarnegar R , BrownMR , HenleyM , TidmanV , PathmanathanA . Patient perceptions and recall of consent for regional anaesthesia compared with consent for surgery . J. R. Soc. Med.108 ( 11 ), 451 – 456 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Haga SB , BurkeW , GinsburgGS , MillsR , AgansR . Primary care physicians’ knowledge of and experience with pharmacogenetic testing . Clin. Genet.82 ( 4 ), 388 – 394 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Selkirk CG , WeissmanSM , AndersonA , HulickPJ . Physicians’ preparedness for integration of genomic and pharmacogenetic testing into practice within a major healthcare system . Genet. Test. Mol. Biomarkers17 ( 3 ), 219 – 225 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Stanek EJ , SandersCL , TaberKAet al. Adoption of pharmacogenomic testing by US physicians: results of a nationwide survey . Clin. Pharmacol. Ther.91 ( 3 ), 450 – 458 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Unertl KM , FieldJR , PriceL , PetersonJF . Clinician perspectives on using pharmacogenomics in clinical practice . Per. Med.12 ( 4 ), 339 – 347 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Wolff AC , HammondME , HicksDGet al. Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update . J. Clin. Oncol.31 ( 31 ), 3997 – 4013 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Mills R , VooraD , PeyserB , HagaSB . Delivering pharmacogenetic testing in a primary care setting . Pharmacogenom. Per. Med.6 , 105 – 112 ( 2013 ).
   PubMedGoogle Scholar
• Glicksman JT , ShermanI , RotenbergBW . Informed consent when prescribing medication: a randomized controlled trial . Laryngoscope124 ( 6 ), 1296 – 1300 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Jackson L , GoldsmithL , SkirtonH . Guidance for patients considering direct-to-consumer genetic testing and health professionals involved in their care: development of a practical decision tool . Fam. Pract.31 ( 3 ), 341 – 348 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Centers for Medicare & Medicaid Services . Part 7: Using readability formulas: a cautionary note . In : Toolkit for making written material clear and effective , ( Eds ). www.cms.gov/Outreach-and-Education/Outreach/WrittenMaterialsToolkit/index.html .
   Google Scholar